Weiren Liu

4PUBLICATIONS

16CO-AUTHORS

Haematological tumoursMolecular targetsGene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Sep 01, 2026

Metabolic Reprogramming of NSUN2-Mediated m5C Modification Promotes the Progression of Hepatocellular Carcinoma by Restricting Natural Killer Cell-Mediated Cytotoxicity.

|Nov 24, 2025

Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma.

Shiguang Yang, Shaoqing Liu, Jie Li

|May 02, 2025

Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma.

Wei-Feng Qu, Gui-Qi Zhu, Rui Yang

|Jul 07, 2023

Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.

Jun Gao, Yuan Fang, Jiafeng Chen

Pageof 1

Frequent Collaborators

3 joint publications

Yinghong Shi

2 joint publications

Guiqi Zhu

2 joint publications

Yichao Bu

2 joint publications

Jian Zhou

2 joint publications

Jia Fan

1 joint publications

Wei-Feng Qu

1 joint publications

Rui Yang

1 joint publications

Tian-Hao Chu

1 joint publications

Zhi-Qi Guan

1 joint publications

Qian-Fu Zhao

Frequent Collaborators

3 joint publications

Yinghong Shi

2 joint publications

Guiqi Zhu

2 joint publications

Yichao Bu

2 joint publications

Jian Zhou